Healthcare Providers and Services
Company Overview of InfuSystem Holdings Inc.
InfuSystem Holdings Inc., through its subsidiaries, provides infusion pumps, and related products and services in the United States and Canada. It supplies electronic ambulatory infusion pumps and associated disposable supply kits to oncology clinics, infusion clinics, hospital outpatient, and chemotherapy clinics for the treatment of various cancers, including colorectal cancer, pain management, and other disease states. The company also sells, rents, and leases new and pre-owned pole mounted and ambulatory infusion pumps; and provides biomedical recertification, maintenance, and repair services for oncology practices, as well as other alternate site settings comprising home care and home i...
31700 Research Park Drive
Madison Heights, MI 48071
Founded in 2005
Key Executives for InfuSystem Holdings Inc.
Executive VP, COO, Compliance Officer, Privacy Officer & Member of Office - President
Total Annual Compensation: $321.3K
Compensation as of Fiscal Year 2016.
InfuSystem Holdings Inc. Key Developments
InfuSystem Holdings, Inc Announces Executive Changes
Feb 7 18
InfuSystem Holdings Inc. announced that its interim chief financial officer, Christopher Downs, has informed the Company of his decision to resign his position with the company, effective March 31, 2018. Mr. Downs resignation does not reflect any dispute or disagreement with the Company, nor does it relate to any issues with respect to the Company's financial performance. Following Mr. Downs's departure, Trent Smith, CPA, the company's executive vice president, corporate controller and chief accounting officer will assume Mr. Downs's responsibilities as treasurer and principal financial officer. The Company will immediately begin a search for a new chief financial officer. Mr. Downs has agreed to continue in his position as interim chief financial officer until the end of the current quarter in order to assist the Company with the preparation and reporting of its annual financial statements.
InfuSystem Holdings, Inc. Announces Dismissal of Class Action Shareholder Lawsuit
Jan 31 18
InfuSystem Holdings Inc. announced it has received notice that on January 29, 2018 the United States District Court for the Central District of California has issued an order dismissing, with prejudice, a putative class-action lawsuit against the company. The dismissal relates to an action brought on November 8, 2016 by a purported shareholder of the Company (Case No. 2:16-cv-08295-ODW) against the Company and two individual defendants: Eric Steen, the Company's former Chief Executive Officer, President and Director; and Jonathan Foster, the Company's former Chief Financial Officer. The complaint asserted claims against all defendants under the antifraud provisions of the federal securities laws and against Messrs. Steen and Foster as control persons. On June 19, 2017, the Company and all defendants filed a Motion to Dismiss the amended complaint. On December 15, 2017, the Court dismissed the plaintiff's first amendment to the class action compliant, with leave to amend. On December 20, 2017, the parties stipulated, and the Court extended, the plaintiff's time to amend the FAC up to January 19, 2018. As of January 19, 2018, the plaintiff never filed an amended complaint and the Court dismissed the lawsuit with prejudice on January 29, 2018.
InfuSystem Holdings, Inc. Appoints Richard Dilorio as President and Chief Executive Officer
Nov 16 17
InfuSystem Holdings Inc. announced the appointment of Richard DiIorio as President and Chief Executive Officer, effective November 15, 2017. Mr. DiIorio has been elected to serve on the company's Board of Directors. With Mr. DiIorio's appointment, the Office of the President will cease to operate. Mr. DiIorio brings a strong track record of accomplishment with more than seventeen years of medical sales experience, extensive expertise in product launch, and industry knowledge focused on driving growth in the oncology market. Mr. DiIorio has served as a member of the Company's Office of the President since May 2017 and as General Manager of Oncology since December 2016.
Similar Private Companies By Industry
Recent Private Companies Transactions
June 19, 2017